Your browser doesn't support javascript.
loading
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study.
Heiblig, Maël; Ferrada, Marcela A; Koster, Matthew J; Barba, Thomas; Gerfaud-Valentin, Mathieu; Mékinian, Arsène; Coelho, Henrique; Fossard, Gaelle; Barraco, Fiorenza; Galicier, Lionel; Bienvenu, Boris; Hirsch, Pierre; Vial, Guillaume; Boutin, Anne Blandine; Galland, Joris; Le Guenno, Guillaume; Bigot, Adrien; Warrington, Kenneth J; Kermani, Tanaz A; Grayson, Peter C; Patel, Bhavisha A; Beck, David B; Jamilloux, Yvan; Fenaux, Pierre; Sujobert, Pierre.
Afiliação
  • Heiblig M; Service d'Hématologie Clinique, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
  • Ferrada MA; National Institute of Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD.
  • Koster MJ; Division of Rheumatology, Mayo Clinic, Rochester, MN.
  • Barba T; Department of Internal Medicine, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France.
  • Gerfaud-Valentin M; Internal Medicine, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon Imunopathology Federation (LIFE), Lyon, France.
  • Mékinian A; Department of Internal Medicine, Assistance Publique Hôpitaux de Paris, Hôpital Saint Antoine, Paris, France.
  • Coelho H; Department of Hematology, Centro Hospitalar Vila Nova de Gaia, Porto, Portugal.
  • Fossard G; Service d'Hématologie Clinique, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
  • Barraco F; Service d'Hématologie Clinique, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
  • Galicier L; Department of Internal Medicine, Hôpital Saint Joseph, Marseille, France.
  • Bienvenu B; Department of Internal Medicine, Hôpital Saint Joseph, Marseille, France.
  • Hirsch P; Service d'Hématologie Biologique, Sorbonne Université, Assistance Publique Hôpitaux de Paris, Hôpital Saint Antoine, Paris, France.
  • Vial G; Department of Internal Medicine and Clinical Immunology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
  • Boutin AB; Department of Hematology, Centre Hospitalier Alpes Léman, Contamine sur Arve, France.
  • Galland J; Internal Medicine, Hopital Fleyriat, Centre Hospitalier Bourg-en-Bresse, Bourg-en-Bresse, France.
  • Le Guenno G; Service de Médecine Interne, Centre Hospitalier Universitaire d'Estaing, Clermont Ferrand, France.
  • Bigot A; CHRU De Tours, Tours, France.
  • Warrington KJ; Division of Rheumatology, Mayo Clinic, Rochester, MN.
  • Kermani TA; University of California Los Angeles, Los Angeles, CA.
  • Grayson PC; National Institute of Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD.
  • Patel BA; Hematology Branch, National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD.
  • Beck DB; National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.
  • Jamilloux Y; New York University, New York, NY.
  • Fenaux P; Internal Medicine, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon Imunopathology Federation (LIFE), Lyon, France.
  • Sujobert P; Assistance Publique Hôpitaux de Paris, Hôpital Saint-Louis and Université de Paris, Paris, France; and.
Blood ; 140(8): 927-931, 2022 08 25.
Article em En | MEDLINE | ID: mdl-35609174
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article